Patents Assigned to Chimer
  • Patent number: 5487993
    Abstract: Methods are described for producing recombinant DNA molecules from suitable host vectors and nucleic acids subjected to 3'-terminal transferase activity. In one embodiment, the method takes advantage of the single 3'-deoxy-adenosine monophosphate (dAMP) residues attached to the 3' termini of PCR generated nucleic acids. Vectors are prepared with recognition sequences that afford single 3'-terminal deoxy-thymidine monophosphate (dTMP) residues upon reaction with a suitable restriction enzyme. Thus, PCR generated copies of genes can be directly cloned into the vectors without need for preparing primers having suitable restriction sites therein. The invention also contemplates associated plasmid vectors and kits for implementing the methods.
    Type: Grant
    Filed: September 9, 1993
    Date of Patent: January 30, 1996
    Assignees: Invitrogen Corporation, Chimer
    Inventors: Corinna Herrnstadt, Joseph M. Fernandez, Lloyd Smith, David A. Mead